Work

177Lu-DOTATATE PRRT Safety and Organ-at-Risk Dosimetry in Patients With Gastroenteropancreatic Neuroendocrine Tumors

Year: 2024

Type: article

Study design: Clinical Trial

Source: Clinical Nuclear Medicine

DOI: 10.1097/rlu.0000000000005330

Authors: Magdalena Mileva, Camille Van Bogaert, Gwennaëlle Marin, Rachele Danieli, Carlos Artigas, Hugo Levillain, Lieveke Ameye, Loubna Taraji-Schiltz, Konstantinos Stathopoulos, Zéna Wimana, Alain Hendlisz, Patrick Flamen, Ioannis Karfis

Institutions: Institut Jules Bordet, Erasmus Hospital, Université Libre de Bruxelles

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4399934603

FWCI: 2.575

Cites: 41

Cited by: 10

Related to: 10